SlideShare a Scribd company logo
National Programme for
Tuberculosis Control and Chest
Diseases-NPTCCD
Dr. Kanthi Ariyarathne, Director/NPTCCD, Sri Lanka.
Vision: Sri Lanka free of
Tuberculosis and other
respiratory diseases
NTRL
NPTCCD Central
Unit
NHRD
DCCs
Gene xpert Machines for the
provinces……
• NHSL
• DCC Kandy
• TH Galle Karapitiya
• TH Anuradhapura
• TH Baticaloa
• PGH Rathnapura
• PGH Badulla
• PGH Kurunegala
9695
8946
9155
9614 9788
10095
10329
9343 9496 9473 9575
8886
8983
8283
8497
8996 9118
9328 9508
8507
8767 8692
8990
8332
7066
6347 6513
6829 6760 6780 6896
6158 6304 6124 6291
5807
4868
4442 4528 4683 4764 4635 4490
4269 4423 4293 4299
4093
2198
1905 1985
2146 1996 2145
2406
1889 1881 1831 1992
1714
1917 1936 1984
2167 2358
2548 2612
2349 2463 2568 2699 2525
510 435 438 394 409 380 395 433 410 456 573 550
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
numberofcases
Case Detection of Tuberculosis - 2005 - 2016
All Cases
All New
PTB
PTB +ve
PTB -ve
EXTRA
PTB
Retreatme
nt
Cases
120
437
648
839
1167 1194
1068
143
421 432 409
457
505 492
263
858
1080
1248
1624
1699
1560
0
200
400
600
800
1000
1200
1400
1600
1800
0 - 14 15 - 24 25 - 34 35 - 44 45 - 54 55 - 64 65 +
NumberofCases Distribution of new cases (PTB and EPTB) by age and sex categories in SL 2016
Male Female All New Cases
Treatment Outcome
86.8
87.1
82.9
83.2 83.2
84.1
6.2
5.1
5.5
5.7
6.9 6.8
1.0
0.8 0.7
0.9 1.1 1.1
3.5
3.9
4.6
4.8
4.5
4.2
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
80.0
81.0
82.0
83.0
84.0
85.0
86.0
87.0
88.0
2010 2011 2012 2013 2014 2015
Death,LosstofollowupandFailurerate
TreatmentSuccessRate
Treatment Outcome of All Forms of TB 2010 - 2015
Treatment success Died Failure Loss to follow up
TB and HIV Screening 2016
TB and HIV Screening
2017 Q2
1015
1832
3379
4646
7409
7827 7952
3912
10.1
17.7
36.2
48.9
78.2
81.7
89.5
94.4
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
2010 2011 2012 2013 2014 2015 2016 2017 up to
Q2
Percentage
NumberScreened
Number Screened Percentage
TB HIV Co-Infection 2013 - 2017
up to Q2
9
25
20
7 7
6
12
17
5 5
15
37 37
12 12
0
5
10
15
20
25
30
35
40
2013 2014 2015 2016 2017 up to Q2
TB HIV HIV TB TB HIV Cor-Infection
Burden in summary…..
 13,500 expected cases per year, but only about 9,000
notified: 4-5,000 missing
 TB cases getting older: 39% of cases notified in 2014 were
45+, 43% in 2016
 Few children diagnosed
 High burden in prisoners (1.68%)
 >90% testing for HIV, but PLHIV few
 Uncertain burden in diabetics, smokers, malnourished
 Treatment success <85%
Challenges
 No acceleration of TB control
 M&E inconsistent, so results are uncertain
 Screening of out-patients is not done as expected
 Microscopy facilities lacking in big hospitals
 Contact screening is not happening as expected
 Haphazard active case finding
 Low paeditric patients detection
 NSP not on target
 Multiple plans
 Strengthening of NPTCCD required
 Replace Category II treatment with DST and appropriate regimen
 Infection control in the clinics required
Opportunities…..
 Low burden of TB
 Universal health coverage
 Well-equipped hospitals
 Well-trained respiratory physicians
 Strong DTCOs and district teams
 Strong Primary Care network
 General Prctioner network
 Availability of Private hospitals
 Possible collaboration with NCDs/Diabetes/CKDU prevention
programmes
 Social support improvement
Business as usual is not an option.
 Consequence is delay, late diagnosis, extensive
disease, and higher risk of death
 Unless case finding and programme performance
can be substantially improved, Sri Lanka will miss
the WHO End TB Strategy targets for 2030.
 Unless radical steps are taken to address these
challenges, no substantial progress will be made.
TB control priorities for Sri
Lanka
 A Strategic Health Communication Campaign
 Strengthen the screening of contacts and high risk groups
like Prisoners and HIV positives /AIDS patients
 Involvement of private health sector
 Involvement of Non Governmental Organizations
&Business community
 Involvement of other Ministries like Education ,Social
Welfare and Media
 Operational Research for greater understanding of
patients’ pathways to TB care
To improve case finding…..
 Pilot Districts-NTP Central Unit will set up 2-3 pilot
districts, in collaboration with provincial and regional
health directors to prove that addressing the challenges
above can significantly increase case finding within one
year, and improve treatment outcome
 Patient Centered services-NTP will ensure patient-
centered services are provided. All hospitals without
microscopy facilities in OPD should set them up, diagnose
TB cases, register them and initiate treatment on
bacteriologically confirmed cases.
To improve case finding…..
 Strengthen monitoring and supervision –NTP Central Unit and
DTCOs should provide constant supportive supervision.
 Strengthen contact tracing activities-By setting targets for the
PHIs and DTCO to find all contacts and increase the sensitivity
of contact screening by performing chest X-rays.
 Active case finding in high risk populations- By strengthening
activities for prison inmates , household contacts and PLHIV.
 Introduction of web based record systems -A laboratory
information system and an electronic case-based patient
record system for TB patients.
Treatment Regimen & Operational
Research
 Treatment Regimen - Urgently phase out Category II
treatment in favour of drug susceptibility testing for all
patients requiring re-treatment, with provision of a
regimen that is appropriate for the resistance pattern
found.
 Operational Research-The operational research for greater
understanding of patient’s pathways to TB care ,
performance of TB diagnostic and treatment practices of
the private sector
Programme Management
 Policy-There should be one policy, one plan and one
surveillance system.
 Leadership- Advocate the leadership (political and
administrative )for strengthening the support
 Central Unit-Strengthen the NPTCCD Central Unit with
appropriately trained and committed staff
 DTCO -Strengthen the District Chest Clinics with required
human resources in order to improve control activities
Join together to End TB in Sri Lanka
Thank You

More Related Content

What's hot

Outbreak Investigation
Outbreak InvestigationOutbreak Investigation
Outbreak Investigation
Devendra Niranjan
 
Fever & Rash
Fever & RashFever & Rash
Fever & Rash
bausher willayat
 
Measurement of malaria
Measurement of malariaMeasurement of malaria
Measurement of malaria
Sachin Patne
 
2. fever with rash
2. fever with rash2. fever with rash
2. fever with rash
Whiteraven68
 
Unit 1 - Introduction to Public Health Administration & Management (BPH 306.2...
Unit 1 - Introduction to Public Health Administration & Management (BPH 306.2...Unit 1 - Introduction to Public Health Administration & Management (BPH 306.2...
Unit 1 - Introduction to Public Health Administration & Management (BPH 306.2...
Dipesh Tikhatri
 
Dengue ppt
Dengue pptDengue ppt
International health
International healthInternational health
International health
Dr. Dharmendra Gahwai
 
Nipah virus
Nipah virusNipah virus
Nipah virus
Devendra Niranjan
 
Hiv aids lecture
Hiv aids lectureHiv aids lecture
Hiv aids lecture
TeamPulaw
 
EPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIAEPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIA
MAHESWARI JAIKUMAR
 
Fever And Rash
Fever And RashFever And Rash
Fever And Rash
MedicineAndDermatology
 
National framework for malaria elimination in india
National framework for malaria elimination in indiaNational framework for malaria elimination in india
National framework for malaria elimination in india
Aparna Chaudhary
 
Japanese encephalitis epidemiology
Japanese encephalitis epidemiologyJapanese encephalitis epidemiology
Japanese encephalitis epidemiology
utpal sharma
 
NVBDCP 2019
NVBDCP 2019NVBDCP 2019
NVBDCP 2019
Mohini Jogdand
 
Indicators of malaria control
Indicators of malaria controlIndicators of malaria control
Indicators of malaria control
Rizwan S A
 
Chicken pox @ daa july 15
Chicken pox @ daa july 15Chicken pox @ daa july 15
Chicken pox @ daa july 15
DR AVADHESH AGRAWALA
 
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
Epidemiology and control of filariasis (Lymphatic Filariasis) in IndiaEpidemiology and control of filariasis (Lymphatic Filariasis) in India
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
Reshma Ann Mathew
 
global polio eradication and endgame strategy
global polio eradication and endgame strategyglobal polio eradication and endgame strategy
global polio eradication and endgame strategy
Dr Arun Kumar Pandey
 
Outbreak – investigation & management
Outbreak – investigation & managementOutbreak – investigation & management
Outbreak – investigation & management
Jeba Jane
 
EPIDEMIOLOGY OF MEASELS
EPIDEMIOLOGY OF MEASELSEPIDEMIOLOGY OF MEASELS
EPIDEMIOLOGY OF MEASELS
MAHESWARI JAIKUMAR
 

What's hot (20)

Outbreak Investigation
Outbreak InvestigationOutbreak Investigation
Outbreak Investigation
 
Fever & Rash
Fever & RashFever & Rash
Fever & Rash
 
Measurement of malaria
Measurement of malariaMeasurement of malaria
Measurement of malaria
 
2. fever with rash
2. fever with rash2. fever with rash
2. fever with rash
 
Unit 1 - Introduction to Public Health Administration & Management (BPH 306.2...
Unit 1 - Introduction to Public Health Administration & Management (BPH 306.2...Unit 1 - Introduction to Public Health Administration & Management (BPH 306.2...
Unit 1 - Introduction to Public Health Administration & Management (BPH 306.2...
 
Dengue ppt
Dengue pptDengue ppt
Dengue ppt
 
International health
International healthInternational health
International health
 
Nipah virus
Nipah virusNipah virus
Nipah virus
 
Hiv aids lecture
Hiv aids lectureHiv aids lecture
Hiv aids lecture
 
EPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIAEPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIA
 
Fever And Rash
Fever And RashFever And Rash
Fever And Rash
 
National framework for malaria elimination in india
National framework for malaria elimination in indiaNational framework for malaria elimination in india
National framework for malaria elimination in india
 
Japanese encephalitis epidemiology
Japanese encephalitis epidemiologyJapanese encephalitis epidemiology
Japanese encephalitis epidemiology
 
NVBDCP 2019
NVBDCP 2019NVBDCP 2019
NVBDCP 2019
 
Indicators of malaria control
Indicators of malaria controlIndicators of malaria control
Indicators of malaria control
 
Chicken pox @ daa july 15
Chicken pox @ daa july 15Chicken pox @ daa july 15
Chicken pox @ daa july 15
 
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
Epidemiology and control of filariasis (Lymphatic Filariasis) in IndiaEpidemiology and control of filariasis (Lymphatic Filariasis) in India
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
 
global polio eradication and endgame strategy
global polio eradication and endgame strategyglobal polio eradication and endgame strategy
global polio eradication and endgame strategy
 
Outbreak – investigation & management
Outbreak – investigation & managementOutbreak – investigation & management
Outbreak – investigation & management
 
EPIDEMIOLOGY OF MEASELS
EPIDEMIOLOGY OF MEASELSEPIDEMIOLOGY OF MEASELS
EPIDEMIOLOGY OF MEASELS
 

Similar to SS 2017: National Programme for Tuberculosis Control and Chest Diseases-NPTCCD

RNTCP-Basic Presantation.ppt
RNTCP-Basic Presantation.pptRNTCP-Basic Presantation.ppt
RNTCP-Basic Presantation.ppt
NandiniMengar
 
Updated_Field Presentation Format_Akwa Ibom.pptx
Updated_Field Presentation Format_Akwa Ibom.pptxUpdated_Field Presentation Format_Akwa Ibom.pptx
Updated_Field Presentation Format_Akwa Ibom.pptx
UzuazoOnwah1
 
RNTCP programme.pdf
RNTCP programme.pdfRNTCP programme.pdf
RNTCP programme.pdf
Dr Shubhangi (Kshirsagar) Hedau
 
Improving malaria treatment and control through enhanced diagnostic practice
Improving malaria treatment and control through enhanced diagnostic practiceImproving malaria treatment and control through enhanced diagnostic practice
Improving malaria treatment and control through enhanced diagnostic practice
ACT Consortium
 
current hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overviewcurrent hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overview
ikramdr01
 
TB_care___Control_update.pdf
TB_care___Control_update.pdfTB_care___Control_update.pdf
TB_care___Control_update.pdf
DharmendraKumarPande5
 
Integrated Disease Surveillance Project
Integrated Disease Surveillance ProjectIntegrated Disease Surveillance Project
Integrated Disease Surveillance Project
Sandeep Das
 
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIANATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
Bharat Masal
 
NACP Basics
NACP BasicsNACP Basics
NACP Basics
Spurthi Magdum
 
Rntcp with emphasis on recent advances
Rntcp with emphasis on recent advancesRntcp with emphasis on recent advances
Rntcp with emphasis on recent advances
Sourav Pattanayak
 
Ncepod
NcepodNcepod
BoDILC2020_Public-health_FINAL_29AUG20.pptx
BoDILC2020_Public-health_FINAL_29AUG20.pptxBoDILC2020_Public-health_FINAL_29AUG20.pptx
BoDILC2020_Public-health_FINAL_29AUG20.pptx
Dunakanshon
 
Pen package
Pen packagePen package
Pen package
Shalli Bavoria
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
European Centre for Disease Prevention and Control
 
Drug Resistant Tuberculosis Management Guideline
Drug Resistant Tuberculosis Management GuidelineDrug Resistant Tuberculosis Management Guideline
Drug Resistant Tuberculosis Management Guideline
Nabin Bist
 
UK Diagnostics Summit 2019
UK Diagnostics Summit 2019UK Diagnostics Summit 2019
UK Diagnostics Summit 2019
4 All of Us
 
National AIDS Control Programme
National AIDS Control ProgrammeNational AIDS Control Programme
National AIDS Control Programme
Dr.Virender pal Singh
 
national aids control program phase IV
national aids control program phase IVnational aids control program phase IV
national aids control program phase IV
Arkadeb Kar
 
IDSP
IDSPIDSP
The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015
Cheryl Johnson
 

Similar to SS 2017: National Programme for Tuberculosis Control and Chest Diseases-NPTCCD (20)

RNTCP-Basic Presantation.ppt
RNTCP-Basic Presantation.pptRNTCP-Basic Presantation.ppt
RNTCP-Basic Presantation.ppt
 
Updated_Field Presentation Format_Akwa Ibom.pptx
Updated_Field Presentation Format_Akwa Ibom.pptxUpdated_Field Presentation Format_Akwa Ibom.pptx
Updated_Field Presentation Format_Akwa Ibom.pptx
 
RNTCP programme.pdf
RNTCP programme.pdfRNTCP programme.pdf
RNTCP programme.pdf
 
Improving malaria treatment and control through enhanced diagnostic practice
Improving malaria treatment and control through enhanced diagnostic practiceImproving malaria treatment and control through enhanced diagnostic practice
Improving malaria treatment and control through enhanced diagnostic practice
 
current hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overviewcurrent hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overview
 
TB_care___Control_update.pdf
TB_care___Control_update.pdfTB_care___Control_update.pdf
TB_care___Control_update.pdf
 
Integrated Disease Surveillance Project
Integrated Disease Surveillance ProjectIntegrated Disease Surveillance Project
Integrated Disease Surveillance Project
 
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIANATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
 
NACP Basics
NACP BasicsNACP Basics
NACP Basics
 
Rntcp with emphasis on recent advances
Rntcp with emphasis on recent advancesRntcp with emphasis on recent advances
Rntcp with emphasis on recent advances
 
Ncepod
NcepodNcepod
Ncepod
 
BoDILC2020_Public-health_FINAL_29AUG20.pptx
BoDILC2020_Public-health_FINAL_29AUG20.pptxBoDILC2020_Public-health_FINAL_29AUG20.pptx
BoDILC2020_Public-health_FINAL_29AUG20.pptx
 
Pen package
Pen packagePen package
Pen package
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
 
Drug Resistant Tuberculosis Management Guideline
Drug Resistant Tuberculosis Management GuidelineDrug Resistant Tuberculosis Management Guideline
Drug Resistant Tuberculosis Management Guideline
 
UK Diagnostics Summit 2019
UK Diagnostics Summit 2019UK Diagnostics Summit 2019
UK Diagnostics Summit 2019
 
National AIDS Control Programme
National AIDS Control ProgrammeNational AIDS Control Programme
National AIDS Control Programme
 
national aids control program phase IV
national aids control program phase IVnational aids control program phase IV
national aids control program phase IV
 
IDSP
IDSPIDSP
IDSP
 
The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015
 

More from Sri Lanka College of Sexual Health and HIV Medicine

Sexual Health a life cycle perspective
Sexual Health a life cycle perspectiveSexual Health a life cycle perspective
Sexual Health a life cycle perspective
Sri Lanka College of Sexual Health and HIV Medicine
 
SS2017: Understanding gender identity
SS2017: Understanding gender identitySS2017: Understanding gender identity
SS2017: Understanding gender identity
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Challenges in Hepatitis B Vaccination
SS 2017: Challenges in Hepatitis B VaccinationSS 2017: Challenges in Hepatitis B Vaccination
SS 2017: Challenges in Hepatitis B Vaccination
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infectionSS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infection
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Immunotherapy for Genital HPV
SS 2017: Immunotherapy for Genital HPV SS 2017: Immunotherapy for Genital HPV
SS 2017: Immunotherapy for Genital HPV
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Anal Cancer and its precursors and clinical implications
SS 2017: Anal Cancer and its precursorsand clinical implicationsSS 2017: Anal Cancer and its precursorsand clinical implications
SS 2017: Anal Cancer and its precursors and clinical implications
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Prevention of cervical cancer
SS 2017: Prevention of cervical cancerSS 2017: Prevention of cervical cancer
SS 2017: Prevention of cervical cancer
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Novel Strategies to Improve STI Screening
SS 2017: Novel Strategies to Improve STI ScreeningSS 2017: Novel Strategies to Improve STI Screening
SS 2017: Novel Strategies to Improve STI Screening
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: The resistance march
SS 2017: The resistance marchSS 2017: The resistance march
SS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
SS 2017: Pre-exposure prophylaxis Sexually Transmitted InfectionsSS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
SS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Syphilis in post elimination era - control strategies
SS 2017: Syphilis in post elimination era - control strategiesSS 2017: Syphilis in post elimination era - control strategies
SS 2017: Syphilis in post elimination era - control strategies
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”
Sri Lanka College of Sexual Health and HIV Medicine
 
SS 2017: Diagnosis of Vaginal Conditions
SS 2017: Diagnosis of Vaginal ConditionsSS 2017: Diagnosis of Vaginal Conditions
SS 2017: Diagnosis of Vaginal Conditions
Sri Lanka College of Sexual Health and HIV Medicine
 
Detection of HIV-TB co infection New approaches
Detection of HIV-TB co infectionNew approachesDetection of HIV-TB co infectionNew approaches
Detection of HIV-TB co infection New approaches
Sri Lanka College of Sexual Health and HIV Medicine
 
CPD 2017: HIV Histopathology
CPD 2017: HIV HistopathologyCPD 2017: HIV Histopathology
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
Sri Lanka College of Sexual Health and HIV Medicine
 
2016 Sessions: 3 recent advances in oi management
2016 Sessions: 3 recent advances in oi management2016 Sessions: 3 recent advances in oi management
2016 Sessions: 3 recent advances in oi management
Sri Lanka College of Sexual Health and HIV Medicine
 
2016 Sesions: Liver and HIV
2016 Sesions: Liver and HIV2016 Sesions: Liver and HIV
2016 Sessions: Mother to child transmission of HIV
2016 Sessions: Mother to child transmission of HIV2016 Sessions: Mother to child transmission of HIV
2016 Sessions: Mother to child transmission of HIV
Sri Lanka College of Sexual Health and HIV Medicine
 
2016 Sessions: Strategic communication in HIV
2016 Sessions: Strategic communication in HIV2016 Sessions: Strategic communication in HIV
2016 Sessions: Strategic communication in HIV
Sri Lanka College of Sexual Health and HIV Medicine
 

More from Sri Lanka College of Sexual Health and HIV Medicine (20)

Sexual Health a life cycle perspective
Sexual Health a life cycle perspectiveSexual Health a life cycle perspective
Sexual Health a life cycle perspective
 
SS2017: Understanding gender identity
SS2017: Understanding gender identitySS2017: Understanding gender identity
SS2017: Understanding gender identity
 
SS 2017: Challenges in Hepatitis B Vaccination
SS 2017: Challenges in Hepatitis B VaccinationSS 2017: Challenges in Hepatitis B Vaccination
SS 2017: Challenges in Hepatitis B Vaccination
 
SS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infectionSS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infection
 
SS 2017: Immunotherapy for Genital HPV
SS 2017: Immunotherapy for Genital HPV SS 2017: Immunotherapy for Genital HPV
SS 2017: Immunotherapy for Genital HPV
 
SS 2017: Anal Cancer and its precursors and clinical implications
SS 2017: Anal Cancer and its precursorsand clinical implicationsSS 2017: Anal Cancer and its precursorsand clinical implications
SS 2017: Anal Cancer and its precursors and clinical implications
 
SS 2017: Prevention of cervical cancer
SS 2017: Prevention of cervical cancerSS 2017: Prevention of cervical cancer
SS 2017: Prevention of cervical cancer
 
SS 2017: Novel Strategies to Improve STI Screening
SS 2017: Novel Strategies to Improve STI ScreeningSS 2017: Novel Strategies to Improve STI Screening
SS 2017: Novel Strategies to Improve STI Screening
 
SS 2017: The resistance march
SS 2017: The resistance marchSS 2017: The resistance march
SS 2017: The resistance march
 
SS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
SS 2017: Pre-exposure prophylaxis Sexually Transmitted InfectionsSS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
SS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
 
SS 2017: Syphilis in post elimination era - control strategies
SS 2017: Syphilis in post elimination era - control strategiesSS 2017: Syphilis in post elimination era - control strategies
SS 2017: Syphilis in post elimination era - control strategies
 
SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”
 
SS 2017: Diagnosis of Vaginal Conditions
SS 2017: Diagnosis of Vaginal ConditionsSS 2017: Diagnosis of Vaginal Conditions
SS 2017: Diagnosis of Vaginal Conditions
 
Detection of HIV-TB co infection New approaches
Detection of HIV-TB co infectionNew approachesDetection of HIV-TB co infectionNew approaches
Detection of HIV-TB co infection New approaches
 
CPD 2017: HIV Histopathology
CPD 2017: HIV HistopathologyCPD 2017: HIV Histopathology
CPD 2017: HIV Histopathology
 
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
 
2016 Sessions: 3 recent advances in oi management
2016 Sessions: 3 recent advances in oi management2016 Sessions: 3 recent advances in oi management
2016 Sessions: 3 recent advances in oi management
 
2016 Sesions: Liver and HIV
2016 Sesions: Liver and HIV2016 Sesions: Liver and HIV
2016 Sesions: Liver and HIV
 
2016 Sessions: Mother to child transmission of HIV
2016 Sessions: Mother to child transmission of HIV2016 Sessions: Mother to child transmission of HIV
2016 Sessions: Mother to child transmission of HIV
 
2016 Sessions: Strategic communication in HIV
2016 Sessions: Strategic communication in HIV2016 Sessions: Strategic communication in HIV
2016 Sessions: Strategic communication in HIV
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 

SS 2017: National Programme for Tuberculosis Control and Chest Diseases-NPTCCD

  • 1. National Programme for Tuberculosis Control and Chest Diseases-NPTCCD Dr. Kanthi Ariyarathne, Director/NPTCCD, Sri Lanka. Vision: Sri Lanka free of Tuberculosis and other respiratory diseases
  • 2. NTRL NPTCCD Central Unit NHRD DCCs Gene xpert Machines for the provinces…… • NHSL • DCC Kandy • TH Galle Karapitiya • TH Anuradhapura • TH Baticaloa • PGH Rathnapura • PGH Badulla • PGH Kurunegala
  • 3. 9695 8946 9155 9614 9788 10095 10329 9343 9496 9473 9575 8886 8983 8283 8497 8996 9118 9328 9508 8507 8767 8692 8990 8332 7066 6347 6513 6829 6760 6780 6896 6158 6304 6124 6291 5807 4868 4442 4528 4683 4764 4635 4490 4269 4423 4293 4299 4093 2198 1905 1985 2146 1996 2145 2406 1889 1881 1831 1992 1714 1917 1936 1984 2167 2358 2548 2612 2349 2463 2568 2699 2525 510 435 438 394 409 380 395 433 410 456 573 550 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 11000 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 numberofcases Case Detection of Tuberculosis - 2005 - 2016 All Cases All New PTB PTB +ve PTB -ve EXTRA PTB Retreatme nt Cases
  • 4.
  • 5. 120 437 648 839 1167 1194 1068 143 421 432 409 457 505 492 263 858 1080 1248 1624 1699 1560 0 200 400 600 800 1000 1200 1400 1600 1800 0 - 14 15 - 24 25 - 34 35 - 44 45 - 54 55 - 64 65 + NumberofCases Distribution of new cases (PTB and EPTB) by age and sex categories in SL 2016 Male Female All New Cases
  • 6.
  • 7. Treatment Outcome 86.8 87.1 82.9 83.2 83.2 84.1 6.2 5.1 5.5 5.7 6.9 6.8 1.0 0.8 0.7 0.9 1.1 1.1 3.5 3.9 4.6 4.8 4.5 4.2 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 80.0 81.0 82.0 83.0 84.0 85.0 86.0 87.0 88.0 2010 2011 2012 2013 2014 2015 Death,LosstofollowupandFailurerate TreatmentSuccessRate Treatment Outcome of All Forms of TB 2010 - 2015 Treatment success Died Failure Loss to follow up
  • 8. TB and HIV Screening 2016
  • 9. TB and HIV Screening 2017 Q2 1015 1832 3379 4646 7409 7827 7952 3912 10.1 17.7 36.2 48.9 78.2 81.7 89.5 94.4 0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 90.0 100.0 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 2010 2011 2012 2013 2014 2015 2016 2017 up to Q2 Percentage NumberScreened Number Screened Percentage
  • 10. TB HIV Co-Infection 2013 - 2017 up to Q2 9 25 20 7 7 6 12 17 5 5 15 37 37 12 12 0 5 10 15 20 25 30 35 40 2013 2014 2015 2016 2017 up to Q2 TB HIV HIV TB TB HIV Cor-Infection
  • 11. Burden in summary…..  13,500 expected cases per year, but only about 9,000 notified: 4-5,000 missing  TB cases getting older: 39% of cases notified in 2014 were 45+, 43% in 2016  Few children diagnosed  High burden in prisoners (1.68%)  >90% testing for HIV, but PLHIV few  Uncertain burden in diabetics, smokers, malnourished  Treatment success <85%
  • 12. Challenges  No acceleration of TB control  M&E inconsistent, so results are uncertain  Screening of out-patients is not done as expected  Microscopy facilities lacking in big hospitals  Contact screening is not happening as expected  Haphazard active case finding  Low paeditric patients detection  NSP not on target  Multiple plans  Strengthening of NPTCCD required  Replace Category II treatment with DST and appropriate regimen  Infection control in the clinics required
  • 13. Opportunities…..  Low burden of TB  Universal health coverage  Well-equipped hospitals  Well-trained respiratory physicians  Strong DTCOs and district teams  Strong Primary Care network  General Prctioner network  Availability of Private hospitals  Possible collaboration with NCDs/Diabetes/CKDU prevention programmes  Social support improvement
  • 14. Business as usual is not an option.  Consequence is delay, late diagnosis, extensive disease, and higher risk of death  Unless case finding and programme performance can be substantially improved, Sri Lanka will miss the WHO End TB Strategy targets for 2030.  Unless radical steps are taken to address these challenges, no substantial progress will be made.
  • 15. TB control priorities for Sri Lanka  A Strategic Health Communication Campaign  Strengthen the screening of contacts and high risk groups like Prisoners and HIV positives /AIDS patients  Involvement of private health sector  Involvement of Non Governmental Organizations &Business community  Involvement of other Ministries like Education ,Social Welfare and Media  Operational Research for greater understanding of patients’ pathways to TB care
  • 16. To improve case finding…..  Pilot Districts-NTP Central Unit will set up 2-3 pilot districts, in collaboration with provincial and regional health directors to prove that addressing the challenges above can significantly increase case finding within one year, and improve treatment outcome  Patient Centered services-NTP will ensure patient- centered services are provided. All hospitals without microscopy facilities in OPD should set them up, diagnose TB cases, register them and initiate treatment on bacteriologically confirmed cases.
  • 17. To improve case finding…..  Strengthen monitoring and supervision –NTP Central Unit and DTCOs should provide constant supportive supervision.  Strengthen contact tracing activities-By setting targets for the PHIs and DTCO to find all contacts and increase the sensitivity of contact screening by performing chest X-rays.  Active case finding in high risk populations- By strengthening activities for prison inmates , household contacts and PLHIV.  Introduction of web based record systems -A laboratory information system and an electronic case-based patient record system for TB patients.
  • 18. Treatment Regimen & Operational Research  Treatment Regimen - Urgently phase out Category II treatment in favour of drug susceptibility testing for all patients requiring re-treatment, with provision of a regimen that is appropriate for the resistance pattern found.  Operational Research-The operational research for greater understanding of patient’s pathways to TB care , performance of TB diagnostic and treatment practices of the private sector
  • 19. Programme Management  Policy-There should be one policy, one plan and one surveillance system.  Leadership- Advocate the leadership (political and administrative )for strengthening the support  Central Unit-Strengthen the NPTCCD Central Unit with appropriately trained and committed staff  DTCO -Strengthen the District Chest Clinics with required human resources in order to improve control activities
  • 20. Join together to End TB in Sri Lanka Thank You